Oventus Medical (ASX: OVN) Managing Director Dr Chris Hart joined Steve Darling from Proactive to discuss the medical device company that has a unique treatment platform for sleep apnea and snoring. Hart telling Proactive about their growth strategy and also about two deals they recently signed with Aeroflow and Careica in Canada.
Oventus Medical targeting massive growth in North America with Sleep Apnea treatment
Quick facts: Oventus Medical Ltd
Price: 0.24 AUD
Market Cap: $37.98 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Oventus Medical Ltd named herein, including the promotion by the Company of Oventus Medical Ltd in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE